Title : Revefenacin for the treatment of chronic obstructive pulmonary disease.

Pub. Date : 2019 Apr

PMID : 30803279






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Expert commentary: Revefenacin is a new M3 muscarinic receptor antagonist, which could prevent acetylcholine from binding with the muscarinic receptor, making bronchodilation and relieving COPD symptoms. Acetylcholine cholinergic receptor muscarinic 3 Homo sapiens